I-Durvalumab - Ukusetyenziswa, Idosi, Iziphumo Ezingalindelekanga kunye nokunye

Intshayelelo: Yintoni iDurvalumab?

I-Durvalumab yi-antibody ye-monoclonal ekwiqela lamayeza aziwa ngokuba zi-immune checkpoint inhibitors. Isetyenziswa kakhulu kunyango lweentlobo ezithile zomhlaza, kuquka umhlaza wamaphaphu ongengowe-cell encinci (i-NSCLC) kunye ne-urothelial carcinoma. Ngokujolisa kwi-programmed death-ligand 1 (PD-L1), i-Durvalumab inceda ukuphucula impendulo yomzimba kwiiseli zomhlaza, ivumela inkqubo yomzimba ukuba iqaphele kwaye ihlasele ii-tumor ngempumelelo.

Ukusetyenziswa kweDurvalumab

I-Durvalumab ivunyiwe kusetyenziso oluninzi lwezonyango, kubandakanya:

• Umhlaza weMiphunga yeSeli engeNcinane (NSCLC): Isetyenziselwa izigulane ezine-NSCLC yesigaba sesi-3 engasuswayo, ezisifo sazo singakaqhubeki emva konyango lwe-chemotherapy olusekelwe kwi-platinum kunye nonyango lwe-radiation ngaxeshanye.
• Urothelial Carcinoma: I-Durvalumab ifundwe kwi-urothelial carcinoma ephucukileyo okanye esasazekayo kwindawo ethile; ukufumaneka kwayo kunye nemeko yokuvunywa kwayo inokwahluka ngokwengingqi.
• Eminye imiqondiso: Uphando luyaqhubeka ukuze kuhlolwe ukusebenza kwayo kwezinye iintlobo zomhlaza, kuquka umhlaza wentloko nentamo kunye neentlobo ezithile zomhlaza webele.

Ingaba isebenza kanjani

I-Durvalumab isebenza ngokuthintela iproteni ye-PD-L1 efumaneka kumphezulu weeseli zomhlaza. Ngokwesiqhelo, i-PD-L1 ibopha kwii-receptor ze-PD-1 kwiiseli ze-T (uhlobo lweseli yokuzikhusela komzimba), nto leyo ethintela impendulo yomzimba. Ngokuthintela oku kusebenzisana, i-Durvalumab ivumela iiseli ze-T ukuba zihlale zisebenza kwaye zihlasele iiseli zomhlaza ngempumelelo. Ngamazwi alula, inceda inkqubo yomzimba yokuzikhusela ukuba iqaphele kwaye ilwe nomhlaza ngokususa "iibhuleki" ezisetyenziswa ziiseli zomhlaza ukuze zingafunyanwa.

Isisombululo kunye noLawulo

I-Durvalumab ilawulwa nge-intravenous (IV) infusion. Umlinganiselo oqhelekileyo wabantu abadala udla i-10 mg / kg rhoqo kwiiveki ezimbini okanye i-1500 mg nganye kwiiveki ezine, kuxhomekeke kwimeko ethile ephathwayo. I-dosing yabantwana ayizange isungulwe, kwaye ulawulo kufuneka luhlale luqhutywa kwindawo yokunakekelwa kwezempilo apho ukubekwa esweni kweziphumo ebezingalindelekanga ezinokuthi zenzeke.

Iziphumo eziPhakamileyo zeDurvalumab

Iziphumo eziqhelekileyo ze-Durvalumab zinokubandakanya:

• Ukukhathala
• I sizathu
• Uhudo
• Rash
• Isiqhamo

Iziphumo ezibi kakhulu zinokubakho kwaye zinokubandakanya:

• I-pneumonia ebangelwa ngumzimba (ukudumba kwemiphunga)
• IHepatitis (ukudumba kwesibindi)
• I-colitis (ukuvuvukala kwekholoni)
• I-Endocrinopathy (ukungalingani kwehomoni)
• Ukwaliwa kakhulu

Izigulane kufuneka zixele naziphi na iimpawu ezingaqhelekanga kumboneleli wabo wezempilo ngokukhawuleza.

Ukusebenzisana kweziyobisi

I-Durvalumab inokusebenzisana namanye amayeza, anokuchaphazela ukusebenza kwayo okanye ukwandisa umngcipheko wemiphumo emibi. Intsebenziswano enkulu yamachiza ibandakanya:

• Ezinye ii-agent ze-immunotherapy
• I-Corticosteroids (inokunciphisa ukusebenza kweDurvalumab)
• Ugonyo oluphilayo (kufuneka luphetshwe ngexesha lonyango)

Ngalo lonke ixesha wazisa umboneleli wakho wezempilo malunga nawo onke amayeza kunye nezongezo ozithathayo.

Iinzuzo zeDurvalumab

Izibonelelo zeklinikhi zokusebenzisa iDurvalumab ziquka:

• Amazinga aPhuculweyo okuPhila: Izifundo zibonise ukuba iDurvalumab inokukhokelela ekusindeni ixesha elide kwizigulane ezineemhlaza ezithile.
• Iimpendulo ezizinzileyo: Ezinye izigulana zifumana iimpendulo ezihlala ixesha elide kunyango, nokuba sele ziyekile ukusebenzisa amayeza.
• Ubutyhefu obunganeno: Xa kuthelekiswa ne-chemotherapy yendabuko, i-Durvalumab inokuba nemiphumo eyahlukileyo, enokubangela ukuba ubomi bube ngcono ngexesha lonyango.

Ukuchasana kweDurvalumab

Abantu abathile kufuneka bakuphephe ukusebenzisa i-Durvalumab, kuquka:

• Abasetyhini abakhulelweyo okanye abancancisayo, ngenxa yengozi enokubakho kwi-fetus okanye usana.
• Izigulana ezinembali yokuchasana kakhulu ne-Durvalumab okanye nayiphi na inxalenye yayo.
• Izigulane ezinezifo ezisebenzayo okanye ezingalawulekiyo zokuzikhusela komzimba kufuneka zihlolwe ngononophelo, njengoko ukusebenza komzimba kunokwenza ezi meko zibe mandundu.

Izilumkiso kunye nezilumkiso

Ngaphambi kokuqala i-Durvalumab, izigulane kufuneka zihlolwe ngokucokisekileyo, kuquka:

• Uvavanyo lomsebenzi wesibindi ukuvavanya impilo yesibindi.
• Ukuhlola nayiphi na imbali yezifo ezizimele.
• Ukuhlolwa rhoqo kweempawu zeziphumo ebezingalindelekanga ezinxulumene nomzimba ngexesha lonyango.

FAQs

Isetyenziselwa ntoni iDurvalumab?

I-Durvalumab isetyenziselwa ukunyanga iintlobo ezithile zomhlaza, kuquka umhlaza wemiphunga ongengoweeseli ezincinci kunye nomhlaza we-urothelial carcinoma.

Ilawulwa njani iDurvalumab?

Inikwa njengokufakwa kwi-intravenous kwindawo yokhathalelo lwempilo.

Zeziphi iziphumo ebezingalindelekanga eziqhelekileyo?

Iziphumo ebezingalindelekanga eziqhelekileyo ziquka ukudinwa, isicaphucaphu, urhudo, nerhashalala.

Ngaba i-Durvalumab ingasetyenziswa ebantwaneni?

Ukhuseleko kunye nokusebenza kakuhle kweDurvalumab kubantwana ayikasungulwa.

Ndingenza ntoni xa ndiphosa ithamo?

Qhagamshelana nomboneleli wakho wezempilo ukuze ufumane isikhokelo malunga nokuhlengahlengisa ukunyuswa kwakho.

Ngaba i-Durvalumab ikhuselekile ngexesha lokukhulelwa?

Hayi, ayikhuthazwa ukuba isetyenziswe ngexesha lokukhulelwa ngenxa yengozi enokubakho kwi-fetus.

Isebenza njani iDurvalumab?

Ithintela iproteni ye-PD-L1, iphucula amandla omzimba okulwa nomhlaza.

Ndingawathatha amanye amayeza ngeDurvalumab?

Yazisa ugqirha wakho malunga nawo onke amayeza owathathayo, njengoko abanye banokusebenzisana neDurvalumab.

Yintoni endifanele ndiyibeke esweni ngelixa ndikwi-Durvalumab?

Lumka naziphi na iimpawu ezingaqhelekanga, ingakumbi iimpawu zeziphumo ebezingalindelekanga ezinxulumene nomzimba, uze uzixele kugqirha wakho.

Kuya kuthatha ixesha elingakanani ukuthatha i-Durvalumab?

Ubude bexesha lonyango luyahluka ngokusekelwe kwimpendulo yomntu kunye nomhlaza othile onyangwayo; ugqirha wakho uya kukunika isikhokelo.

Amagama eBrand

I-Durvalumab ithengiswa phantsi kwegama le-brand elithi Imfinzi.

isiphelo

I-Durvalumab imele inkqubela phambili ebalulekileyo kunyango lomhlaza, ngakumbi kwizigulane ezinomhlaza wemiphunga ongengoweeseli ezincinci kunye ne-urothelial carcinoma. Ngokuphucula amandla omzimba okujolisa kwiiseli zomhlaza, inika ithemba leziphumo eziphuculweyo kunye nomgangatho wobomi. Njengakweminye imithi, kubalulekile ukuxoxa ngeenzuzo kunye neengozi ezinokubakho nomboneleli wakho wezempilo ukuze kuchongwe isicwangciso sonyango esifanelekileyo kwiimfuno zakho.